Oligonucleotide Manufacturers are Steadily Expanding Their Capabilities

Globally, the oligonucleotide manufacturers are focusing on research and diagnostic, and therapeutic applications. As per the analysis, more than 25 companies provide manufacturing services for oligonucleotides in North America for research and diagnostic applications. It is worth highlighting that Ajinomoto Bio-Pharma Services emerged as the leading player in this domain, closely followed by Integrated DNA Technologies and Biosearch Technologies, within North America. It is worth mentioning that Ajinomoto Bio-Pharma Services offers contract research and manufacturing services for antisense oligonucleotides, aptamers, DNA oligonucleotides, decoy, miRNA, and siRNA. Additionally, the company carries out oligonucleotide manufacturing at all scales of operation at its four manufacturing facilities located in different geographies, including the US, Belgium, Japan and Italy.

Likewise, about 10 companies provide manufacturing services for oligonucleotides in North America for therapeutic applications. It is worth mentioning that Integrated DNA technologies emerged as the leading player in terms of company competitiveness, within North America. It is worth mentioning that this company offers custom synthesis, modification and purification services for a wide range of cGMP grade oligonucleotides, across all scales of operation. The company provides its services through four manufacturing facilities based in three different geographies.

Further, with Europe, more than 20 companies offer manufacturing services for oligonucleotides. Some of the prominent oligonucleotide manufacturers that are currently offering oligonucleotide manufacturing for research and diagnostic application include Kaneka Eurogentec, BioSpring, and Microsynth. Likewise, close to 10 European manufacturers offer oligonucleotide-related manufacturing services for therapeutic applications. It is worth mentioning that Kaneka Eurogentec emerged as the most prominent player offering services for therapeutic application in terms of company competitiveness.

It is worth noting that about 15 companies provide manufacturing services for oligonucleotides in Asia-Pacific region. Some of the most prominent oligonucleotide manufacturers in Asia-Pacific for research and diagnostics applications include Ruibo Bio-Technology, Bioneer and Xcelris. Further, as per our analysis, only three companies, based in Asia-Pacific, provide manufacturing services related to oligonucleotides for therapeutic application. It is worth mentioning that Ruibo Bio-Technology emerged as the most prominent player in this region.

Complete report by Roots Analysis: Oligonucleotide Synthesis, Modification and Purification Services Market: Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030

The "Oligonucleotide Synthesis, Modification and Purification Services Market: Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030" report features a detailed study of the current scenario and future potential of the custom synthesis, modification and purification services market for oligonucleotides, which are intended for research, diagnostic, and therapeutic applications. The study includes in-depth analyses, highlighting the capabilities of service providers engaged in this domain.

Key Questions Answered

• Who are the leading manufacturers of oligonucleotides for use in research, diagnostic and therapeutic applications?
• What are the preferred custom synthesis, modification and purification methods used for oligonucleotides?
• What are the key challenges faced by oligonucleotide manufacturers?
• What kind of partnership models are commonly adopted by industry stakeholders?
• What are the recent expansion initiatives undertaken by service providers within this domain?
• What is the annual clinical and commercial demand for oligonucleotides?
• What is the current, installed manufacturing capacity for oligonucleotides?
• What percentage of oligonucleotide manufacturing operations are outsourced to service providers?
• What are the opportunities in emerging markets for oligonucleotide manufacturing?
• How is the current and future market opportunity likely to be distributed across key market segments?
• What are the anticipated future trends related to oligonucleotide manufacturing?

Roots Analysis provides market research and consulting in the pharmaceutical industry. Focussed on providing an informed and impartial view on key issues facing the industry, our research is primarily driven by an in-depth analysis.